1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,400 | 1,460 | 13:03 | |
| 1,400 | 1,470 | 21.02. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | NanoViricides GAAP EPS of -$0.14 | 2 | Seeking Alpha | ||
| Mi | NanoViricides, Inc. Has Filed its Quarterly Report | 235 | ACCESS Newswire | Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / February 19, 2025 / NanoViricides, Inc. (NYSE... ► Artikel lesen | |
| NANOVIRICIDES Aktie jetzt für 0€ handeln | |||||
| 14.02. | NANOVIRICIDES, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.02. | NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape | 514 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum... ► Artikel lesen | |
| 29.01. | NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025 | 564 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the... ► Artikel lesen | |
| 27.01. | NanoViricides Engages CRO for Phase II Clinical Trial | 711 | ACCESS Newswire | SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase... ► Artikel lesen | |
| 13.01. | NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 | 395 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus... ► Artikel lesen | |
| 08.01. | NanoViricides: Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals | 560 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are... ► Artikel lesen | |
| 23.12.24 | NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape | 1.719 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / December 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), says that its broad-spectrum antiviral drug candidate NV-387 is the best weapon to fight a potential... ► Artikel lesen | |
| 12.12.24 | NANOVIRICIDES, INC. - 8-K, Current Report | 5 | SEC Filings | ||
| 15.11.24 | NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID | 498 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September... ► Artikel lesen | |
| 04.11.24 | NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am | 707 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / November 4, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that... ► Artikel lesen | |
| 22.10.24 | NanoViricides President Dr. Diwan to Present at the PODD Conference | 351 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / October 22, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that... ► Artikel lesen | |
| 15.10.24 | NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology | 523 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that... ► Artikel lesen | |
| 14.10.24 | NanoViricides Inc. (NNVC): Best Nanotech Penny Stock to Buy | 3 | Insider Monkey | ||
| 08.10.24 | InvestorNewsBreaks - NanoViricides Inc. (NYSE American: NNVC) to Discuss Its 'Trojan Horse' Platform Technology at Upcoming Global AMR Summit | 1 | iNVEZZ.com | ||
| 08.10.24 | NanoViricides to Present at the Global AMR Summit 2024 Tomorrow | 490 | ACCESS Newswire | Dr. Diwan to Discuss "Shape-Shifting", "Trojan Horse", Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR SHELTON, CT / ACCESSWIRE / October 8, 2024 / NanoViricides... ► Artikel lesen | |
| 30.09.24 | NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID | 506 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / September 30, 2024 / NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30... ► Artikel lesen | |
| 27.09.24 | NANOVIRICIDES, INC. - 10-K, Annual Report | 3 | SEC Filings | ||
| 26.09.24 | NanoViricides Executes an Agreement Encompassing All Antiviral Drug Treatments With Theracour, Including "Trojan Horse" Drugs | 664 | ACCESS Newswire | SHELTON, CT / ACCESSWIRE / September 26, 2024 / NanoViricides, Inc. (NYSE American.:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that... ► Artikel lesen |
Seite:
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 29,700 | -2,62 % | DAX-Check LIVE: BASF, Bilfinger, Commerzbank, Formycon, Kion, Rheinmetall & Co im Fokus | Vor dem Wochenende ging der DAX mit einem Verlust von 0,44 Prozent aus dem Handel. Die Wochenbilanz fiel aber einmal mehr hervorragend aus. Er legte um rund 3,2 Prozent zu. Worauf es jetzt für den DAX... ► Artikel lesen | |
| ONTO INNOVATION | 154,00 | +0,65 % | Onto Innovation (NYSE:ONTO) Price Target Lowered to $240.00 at Oppenheimer | ||
| GAUZY | 11,490 | -0,86 % | Gauzy partners with MABA for South Korea ADAS expansion | ||
| KOPIN | 1,403 | -1,82 % | Pre-market Movers: Diginex, Vince Holding, CTRL Group, Vertical Aerospace, Kopin | REDWOOD SHORES (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET).In the Green Diginex Limited (DGNX) is up over 107% at... ► Artikel lesen | |
| VEECO INSTRUMENTS | 24,000 | +0,84 % | Veeco Instruments Inc.: Veeco Announces Upcoming Investor Event | ||
| REGION GROUP | 1,325 | +3,05 % | REGION GROUP: Ceasing to be a substantial holder | ||
| DOTZ NANO | 0,046 | -4,17 % | DOTZ NANO LIMITED: DTZ - Small Cap Virtual Investor Conference Corporate Deck | ||
| ZENTEK | 0,985 | +3,14 % | Zentek Subsidiary Albany Graphite Corp. Provides Update on Thermal Purification Testwork Results | GUELPH, ON / ACCESS Newswire / February 14, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is... ► Artikel lesen | |
| ACACIA RESEARCH | 4,040 | -1,94 % | Acacia Research Reports Third Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,460 | 0,00 % | ADVANCE ZINCTEK LIMITED: Half Yearly Report and Accounts | ||
| LEHNER INVESTMENTS | 0,030 | 0,00 % | EQS-News: LEHNER INVESTMENTS AG: Alpay Ece verstärkt den Vorstand | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Personalie
LEHNER INVESTMENTS AG: Alpay Ece verstärkt den Vorstand
25.11.2024 / 16:15 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOFOCUS | 1,000 | 0,00 % | NanoFocus schließt Kapitalerhöhung ab | Die NanoFocus AG hat die beschlossene Kapitalerhöhung gegen Sach- und Bareinlagen durchgeführt. Insgesamt wurden 6.021.664 neue Aktien zu je 1,00 Euro ausgegeben. Davon gingen 4.276.884 Aktien an die... ► Artikel lesen | |
| RIBER | 3,450 | +4,23 % | Riber: 2024 business growth in line with guidance | 2024 business growth in line with guidance Revenues up +5% to €41.2mOrder book at end-2024: €21.7m Bezons (France), January 29, 2025 - 8:00 am (CET) - RIBER, a global market leader for MBE equipment... ► Artikel lesen | |
| GOMSPACE | 0,334 | -3,75 % | GomSpace Group AB: GomSpace reaches a major milestone for positive free cashflow and delivers record revenue in 2024 | GomSpace delivers on promise in the Q4 report. Following solid strengthening of its order backlog in 2024, the company issues guidance for 2025 with more than 25% revenue growth.
Fourth Quarter of 2024... ► Artikel lesen | |
| XTPL | 26,400 | 0,00 % | EQS-News: XTPL S.A.: XTPL posts its highest-ever sales in Q4 2024 with growth prospects for 2025 | Issuer: XTPL S.A.
/ Key word(s): Preliminary Results/Sales Result
XTPL posts its highest-ever sales in Q4 2024 with growth prospects for 2025
22.01.2025 / 09:13 CET/CEST
The... ► Artikel lesen |
Das Unternehmen NANOVIRICIDES INC kann der Branche Nanotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,070 (+5,47 %) liegt der Kurs bei 1,350 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOVIRICIDES INC finden Sie auf Wallstreet Online.
